StonvexLoading…
StonvexStonvexStonvexCore line items from RNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.19B | $12.85B | $9.88B | $6.68B |
Operating Income | $548.81M | $4.01B | $2.75B | $1.27B |
Net Income | $293.38M | $2.68B | $1.92B | $1.01B |
EPS (Diluted) | $6.57 | $56.03 | $39.46 | $20.30 |
Total Assets | $53.72B | $53.80B | $54.50B | $54.73B |
Total Liabilities | $35.16B | $34.59B | $35.53B | $36.88B |
Cash & Equivalents | $1.56B | $1.73B | $1.70B | $1.43B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 42.97M | 43.96M | 46.50M | 47.37M |